WHO Prequalifies More Biosimilars
Celltrion And Mylan See Trastuzumab Biosimilars Added To WHO List
The World Health Organization has recently added further biosimilar versions of trastuzumab to its list of prequalified products, along with Roche’s original trastuzumab and rituximab brands, Herceptin and MabThera/Rituxan.
